Philips CPAP Cancer Lawsuit News

Phillips CPAP Sleep Apnea Device Recall Will Begin Soon But Could Take One Year To Complete

Millions of users could have permanent lung damage from inhaling toxic particles, gasses, and chemicals

Monday, September 6, 2021 - Individuals with sleep apnea that could no longer use their Phillips CPAP sleep apnea machines are relieved today that the company has been granted FDA permission to begin repairing and replacing the defective devices. The company tells visitors to their website that they will replace the current sound abatement foam with new material. The Phillips brand of sleep apnea relief machines was recalled several weeks ago when according to FDA reports, the polyester-based polyurethane (PE-PUR) foam that was designed to muffle the noise the mechanical device made during the night, was heating up and breaking down. The breakdowns occur most in the first-generation DreamStation product family, according to Royal Phillips in the Netherlands. As a result, users inhaled toxic gasses, chemicals, and particles directly into their lungs continuously during the night. Phillips sleep apnea patients were being awakened, not by the symptoms of sleep apnea, but by choking, wheezing, headaches, upper airway irritation, coughing, chest pressure, and sinus infection from inhaling the toxic particles and gasses. As a result, many have experienced lung problems, and some have filed Phillips CPAP cancer lawsuits.

More than 3 million people had used the machine to treat their condition that left them unable to get a solid night's sleep. According to the Cleveland Clinic, "Sleep apnea occurs in about 25% of men and nearly 10% of women. Sleep apnea can affect people of all ages, including babies and children and particularly people over the age of 50 and those who are overweight." Users of the devices that have not had problems and their health care providers are encouraged to monitor the device for signs of foam degradation. If signs of deterioration occur, users or physicians should report the malfunctions on the FDA's MedWatch Voluntary Reporting Form. The FDA warns Phillips CPAP users that have not as of yet complied with the recall, "These issues can result in serious injury, which can be life-threatening, cause permanent impairment, and require medical intervention to prevent permanent damage." Individuals that are affected should keep an eye on the Phillips CPAP website, philips.com/src-update every day to receive updates and specific instructions. Royal Phillps CEO Frans van Houten tells customers, "we are working hard towards a resolution, which includes the deployment of the updated instructions for use and a comprehensive repair and replacement program." He also tells users of the BiPAP and CPAP machines to discontinue use unless they suffer from a sleep condition so severe that the risks outweigh those of the defective device and to consult a physician or medical device provider for their opinion. If you or a loved one were diagnosed with lung cancer or another serious respiratory illness caused by using one of the recalled Philips CPAP, BiPAP, or ventilator devices, you should consult a Phillips recall lawyer for a free, no-cost, no-obligation consultation to see if you may be entitled to damages.

More Recent Philips CPAP Cancer Lawsuit News:

Lawyers for CPAP Cancer Lawsuits

We will represent all persons in involved in a BiPAP or CPAP cancer lawsuit on a contingency basis, meaning there are never any legal fees unless we win compensation in your case. Anyone who developed cancer or another serious side effect as a result of using a Philips CPAP sleep apnea machine or ventilator in --or is a family member of such a person--is eligible to receive a free, no-obligation case review from our attorneys. Simply contact our firm through the online contact form or the chat feature and one of our Philips BiPAP cancer lawyers serving will contact you promptly to discuss your case.



Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.